DILUCA, MONICA MARIA GRAZIA
 Distribuzione geografica
Continente #
EU - Europa 18.436
NA - Nord America 17.001
AS - Asia 16.689
SA - Sud America 1.458
AF - Africa 310
OC - Oceania 65
Continente sconosciuto - Info sul continente non disponibili 6
Totale 53.965
Nazione #
US - Stati Uniti d'America 16.569
CN - Cina 5.323
GB - Regno Unito 4.974
SG - Singapore 4.902
IT - Italia 3.483
DE - Germania 2.886
RU - Federazione Russa 1.741
HK - Hong Kong 1.342
SE - Svezia 1.231
VN - Vietnam 1.121
BR - Brasile 1.036
FR - Francia 850
TR - Turchia 828
IN - India 793
KR - Corea 731
BD - Bangladesh 715
NL - Olanda 668
IE - Irlanda 587
UA - Ucraina 528
FI - Finlandia 445
EU - Europa 338
CA - Canada 263
PL - Polonia 222
JP - Giappone 217
ID - Indonesia 216
GR - Grecia 186
CO - Colombia 178
DK - Danimarca 139
CI - Costa d'Avorio 119
AR - Argentina 98
PH - Filippine 91
ES - Italia 87
MX - Messico 87
CH - Svizzera 86
BE - Belgio 84
IQ - Iraq 64
AU - Australia 56
ZA - Sudafrica 46
AT - Austria 45
EC - Ecuador 38
PK - Pakistan 38
SA - Arabia Saudita 37
PT - Portogallo 30
CL - Cile 29
RO - Romania 29
VE - Venezuela 29
UZ - Uzbekistan 27
IL - Israele 25
CZ - Repubblica Ceca 24
TW - Taiwan 24
MA - Marocco 22
IR - Iran 21
KE - Kenya 20
MY - Malesia 19
TN - Tunisia 19
TH - Thailandia 18
JO - Giordania 17
LT - Lituania 17
PY - Paraguay 16
SC - Seychelles 16
NO - Norvegia 15
NP - Nepal 15
AE - Emirati Arabi Uniti 14
PE - Perù 14
AL - Albania 13
CR - Costa Rica 13
DZ - Algeria 13
EG - Egitto 13
HU - Ungheria 12
UY - Uruguay 12
DO - Repubblica Dominicana 10
JM - Giamaica 10
KZ - Kazakistan 10
LU - Lussemburgo 9
NZ - Nuova Zelanda 9
OM - Oman 9
TT - Trinidad e Tobago 9
AZ - Azerbaigian 8
BH - Bahrain 8
NG - Nigeria 8
ET - Etiopia 7
GT - Guatemala 7
HN - Honduras 7
LB - Libano 7
AM - Armenia 6
BG - Bulgaria 6
BO - Bolivia 6
PA - Panama 6
BA - Bosnia-Erzegovina 5
BY - Bielorussia 5
LA - Repubblica Popolare Democratica del Laos 5
LK - Sri Lanka 5
PS - Palestinian Territory 5
SY - Repubblica araba siriana 5
LV - Lettonia 4
RS - Serbia 4
SI - Slovenia 4
AO - Angola 3
BB - Barbados 3
CY - Cipro 3
Totale 54.217
Città #
Southend 4.403
Singapore 2.906
Ashburn 1.652
Chandler 1.249
Hong Kong 1.243
San Jose 1.186
Beijing 1.143
Milan 1.107
Princeton 745
Dallas 738
Frankfurt am Main 724
Wilmington 654
Seattle 625
Santa Clara 596
Dublin 579
Council Bluffs 565
Fairfield 534
Los Angeles 436
Hanover 380
Redmond 366
Nanjing 360
Ann Arbor 349
Jacksonville 345
Bengaluru 339
Mountain View 319
Woodbridge 319
Ho Chi Minh City 312
Lauterbourg 292
Grafing 283
Hanoi 259
Houston 258
Boardman 247
Dearborn 246
Sakarya 246
New York 243
Moscow 232
Buffalo 222
Somerville 220
Guangzhou 219
Hefei 209
Cambridge 194
Des Moines 193
Shanghai 193
Warsaw 192
Athens 172
Rome 172
Andover 163
Bogotá 159
Jinan 156
Seoul 146
Jakarta 138
Shenyang 136
Tokyo 130
Eitensheim 124
Serra 123
Abidjan 118
Columbus 116
The Dalles 116
São Paulo 108
Tianjin 108
Munich 104
Helsinki 103
Nanchang 103
Cangzhou 99
Berlin 98
Phoenix 97
Hebei 94
Istanbul 91
Medford 89
Saint Petersburg 89
Toronto 89
Hamburg 87
Redwood City 83
Zhengzhou 79
Changsha 72
Hangzhou 72
Shenzhen 71
Brussels 69
Turin 67
Fuzhou 63
Da Nang 58
Sunnyvale 58
London 55
San Diego 51
Montreal 48
Bühl 47
Jiaxing 47
Kunming 47
Naples 46
Nuremberg 45
Chicago 42
Wuhan 42
Silver Spring 41
Atlanta 39
Quanzhou 39
Bitonto 37
Genoa 37
Ningbo 37
Haikou 36
Falls Church 35
Totale 32.913
Nome #
Anti-GluA3 antibodies in frontotemporal dementia: effects on glutamatergic neurotransmission and synaptic failure. 475
Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease 440
Amyloid-β oligomers regulate ADAM10 synaptic localization through aberrant plasticity phenomena 434
Early maternal deprivation immunologically primes hippocampal synapses by redistributing interleukin-1 receptor type I in a sex dependent manner 427
Le basi farmacologiche 420
SNAP-25 regulates spine formation through postsynaptic binding to p140Cap 414
Proximity ligation assay reveals both pre- A nd postsynaptic localization of the APP-processing enzymes ADAM10 and BACE1 in rat and human adult brain 412
The Synaptonuclear Messenger RNF10 Acts as an Architect of Neuronal Morphology 406
SAP97-mediated local trafficking is altered in Alzheimer disease patients' hippocampus 402
A light-gated potassium channel for sustained neuronal inhibition 376
ADAM10 in Alzheimer's disease: Pharmacological modulation by natural compounds and its role as a peripheral marker 354
Farmaci per il sistema nervoso centrale 343
Linking NMDA Receptor Synaptic Retention to Synaptic Plasticity and Cognition 342
Leukotriene D(4)-induced activation of smooth-muscle cells from human bronchi is partly Ca(2+)-independent 336
Rabphilin 3A : a novel target for the treatment of levodopa-induced dyskinesias 336
NMDA receptor gluN2A/gluN2B subunit ratio as synaptic trait of levodopa-induced dyskinesias : from experimental models to patients 323
Adam10 plasma and csf levels are increased in mild Alzheimer’s disease 306
Distribution of interleukin-1 receptor complex at the synaptic membrane driven by interleukin-1β and NMDA stimulation 305
NMDA and AMPA Receptor Autoantibodies in Brain Disorders: From Molecular Mechanisms to Clinical Features 295
Rabphilin-3A as a novel target to reverse α-synuclein-induced synaptic loss in Parkinson's disease 294
Social decision making, hierarchy and emotional contagion are interconnected by the basolateral amygdala 293
Interleukin-1 beta released by gp120 drives neural death through tyrosine phosphorylation and trafficking of NMDA receptors 293
Rabphilin 3A retains NMDA receptors at synaptic sites through interaction with GluN2A/PSD-95 complex 288
The development of ADAM10 endocytosis inhibitors for the treatment of Alzheimer's disease 288
A critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia 282
Synaptic activity controls dendritic spine morphology by modulating eEF2-dependent BDNF synthesis 282
GluA3 autoantibodies induce alterations in dendritic spine and behavior in mice 282
Modeling Alzheimer's disease: from past to future 279
Reciprocal cortico-amygdala connections regulate prosocial and selfish choices in mice 274
NMDA receptor GluN2D subunit participates to levodopa-induced dyskinesia pathophysiology 274
Expression of AMPA and NMDA receptor subunits in the cervical spinal cord of wobbler mice 268
Effect of rasagiline on the molecular composition of the excitatory postsynaptic density 268
Cyclase-associated protein 2 dimerization regulates cofilin in synaptic plasticity and Alzheimer's disease 266
Ring finger protein 10 is a novel synaptonuclear messenger encoding activation of NMDA receptors in hippocampus 264
Interleukin-1β enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases 259
Novel therapeutic approaches to target neurodegeneration 258
Coxsackievirus adenovirus receptor loss impairs adult neurogenesis, synapse content, and hippocampus plasticity 257
N-methyl-D-aspartate (NMDA) receptor composition modulates dendritic spine morphology in striatal medium spiny neurons 256
Epilepsy-induced abnormal striatal plasticity in Bassoon mutant mice 254
Glucose-derived glutamate drives neuronal terminal differentiation in vitro 251
Toward a Glutamate Hypothesis of Frontotemporal Dementia 249
Calcium-calmodulin-dependent protein kinase II phosphorylation modulates PSD-95 binding to NMDA receptors 248
LRRK2 phosphorylation level correlates with abnormal motor behaviour in an experimental model of levodopa-induced dyskinesias 247
Peptidi inibitori dell'endocitosi di ADAM10 e relativi usi nel trattamento della malattia di Alzheimer 247
Anti-AMPA GluA3 antibodies in Frontotemporal dementia: A new molecular target 243
Publisher Correction: Anti-AMPA GluA3 antibodies in Frontotemporal dementia: A new molecular target 242
ADENOSINE MODULATES THE DOPAMINERGIC FUNCTION IN THE NIGRO-STRIATAL SYSTEM BY INTERACTING WITH STRIATAL DOPAMINE DEPENDENT ADENYLATE-CYCLASE 236
Latent profile analysis in frontotemporal lobar degeneration and related disorders : clinical presentation and SPECT functional correlates 233
Elongation factor-2 phosphorylation in dendrites and the regulation of dendritic mRNA translation in neurons 233
Blocking ADAM10 synaptic trafficking generates a model of sporadic Alzheimer's disease 232
An association study of cyclase-associated protein 2 and frailty 228
SAP97-mediated ADAM10 trafficking from Golgi outposts depends on PKC phosphorylation 226
ADAM10 inhibition to treat Fragile X syndrome 226
Synaptic GluN2A-Containing NMDA Receptors: From Physiology to Pathological Synaptic Plasticity 226
Rabphilin-3A Drives Structural Modifications of Dendritic Spines Induced by Long-Term Potentiation 225
Abnormal Ca2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism 225
Amyloid precursor protein metabolism is regulated toward alpha-secretase pathway by Ginkgo biloba extracts 224
ADAM10 regulates dendritic spine morphology and glutamate receptor composition trough N-Cadherin cleavage 224
Modulatory effect of acetyl-L-carnitine on amyloid precursor protein metabolism in hippocampal neurons 223
Acetylcholinesterase inhibitors increase ADAM10 activity by promoting its trafficking in neuroblastoma cell lines 221
A critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia 221
Citochine e sistema glutamatergico neuronale, una relazione pericolosa? 219
Functional correlates of Apolipoprotein E genotype in Frontotemporal Lobar Degeneration 218
Zinc transporter-1: a novel NMDA receptor-binding protein at the postsynaptic density 214
Neuronal PCSK9 regulates cognitive performances via the modulation of ApoER2 synaptic localization 212
ADAM10 regulates dendritic spine morphology and glutamate receptor composition trough N-Cadherin cleavage 212
Protein-protein interactions at the {NMDA} receptor complex: From synaptic retention to synaptonuclear protein messengers 209
SAP97 directs the localization of Kv4.2 to spines in hippocampal neurons : regulation by CaMKII 208
Artificial neural networks allow the use of simultaneous measurements of Alzheimer disease markers for early detection of the disease 206
Synaptic neurofilaments and GluN1-NfL interaction in experimental models of α-synucleinopathies 204
Pattern of Tau forms in CSF is altered in progressive supranuclear palsy 203
Synaptic dysfunction in early phases of Alzheimer's Disease 203
Missense variants in RPH3A cause defects in excitatory synaptic function and are associated with a clinically variable neurodevelopmental disorder 201
Calcium/calmodulin-dependent protein kinase II phosphorylation drives synapse-associated protein 97 into spines 201
ADAM10/SAP97 association is defective in Alzheimer disease patients’ hippocampus 201
Synapse-associated protein-97 mediates alpha-secretase ADAM10 trafficking and promotes its activity 200
ADAM10 regulates dendritic spine morphology and glutamate receptor composition trough N-Cadherin cleavage 199
An innovative model for Alzheimer’s disease 195
Interleukin-1beta and NMDA differently mediate the mobilization of IL-1 receptor type I and its interaction with the NMDA receptor in primary hippocampal neurons 195
Increased [3H]D-aspartate release and changes in glutamate receptor expression in the hippocampus of the mnd mouse 194
Merging amyloid-beta cascade and activity-dependent plasticity in hippocampus : a possible role for ADAM10 193
Arg209Lys and Gln508His missense variants in Rabphilin 3A cause pre- and post-synaptic dysfunctions at excitatory glutamatergic synapses 192
Synaptic localization and activity of ADAM10 regulate excitatory synapses through N-cadherin cleavage 192
The RNF10 protein interacts with the GluN2A subunit of the NMDA-type Glutamate receptor 192
Detrimental effects of soluble α-synuclein oligomers at excitatory glutamatergic synapses 192
SAP97 : THE POINT OF CONVERGENCE BETWEEN AMYLOID CASCADE AND SYNAPTIC DYSFUNCTION IN ALZHEIMER DISEASE PATHOGENESIS 190
Decreased NR2B Subunit Synaptic Levels Cause Impaired Long-Term Potentiation But Not Long-Term Depression 189
Molecular rationale for the pharmacological treatment of Alzheimer's disease 187
Vascular Endothelial Growth Factor genetic variability confers susceptibility to frontotemporal lobar degeneration. 187
The amyloid cascade : the old and the new 186
α-secretase ADAM10 as well as αAPPs is reduced in platelets and CSF of Alzheimer disease patients 186
Dual role of CaMKII-dependent SAP97 phosphorylation in mediating trafficking and insertion of NMDA receptor subunit NR2A 184
Loss of Ryanodine Receptor 2 impairs neuronal activity-dependent remodeling of dendritic spines and triggers compensatory neuronal hyperexcitability 184
Platelets provide human tissue to unravel pathogenic mechanisms of Alzheimer disease 183
IL-1 beta and NMDA receptor : a dangerous liason in neuroaids 183
NMDA and AMPA Receptors at Synapses: Novel Targets for Tau and α-Synuclein Proteinopathies 182
Neonatal exposure to brominated flame retardant BDE-47 reduces long-term potentiation and postsynaptic protein levels in mouse hippocampus 182
Platelet APP, ADAM 10 and BACE alterations in the early stages of Alzheimer disease 182
Endocytosis of synaptic ADAM10 in neuronal plasticity and Alzheimer's disease 182
Alpha, beta-and gamma-secretases in Alzheimer's disease 181
Totale 25.378
Categoria #
all - tutte 158.624
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 158.624


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021303 0 0 0 0 0 0 0 0 0 0 0 303
2021/20223.886 372 149 103 203 357 273 450 224 290 394 374 697
2022/20234.508 666 377 400 474 543 884 85 259 437 47 221 115
2023/20243.467 127 279 274 387 722 260 159 221 61 248 336 393
2024/20257.651 284 663 173 756 712 345 388 870 428 610 724 1.698
2025/202616.664 1.476 930 1.988 1.271 1.703 1.085 2.049 901 1.930 1.140 1.311 880
Totale 56.813